1618403056900_EM prospero en equilibrio

SAVE OFFLINE

13/4/2021

https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=218716

PROSPERO Registro prospectivo internacional de revisiones sistemáticas

Efectos de la hipoterapia o la equitación terapéutica sobre el equilibrio, el control postural y la movilidad funcional en la esclerosis múltiple: un metaanálisis Yawen Yu, Eric Anson, Joshua Haworth, Shelly Lane, Peter Agada

Para permitir que PROSPERO se concentre en los registros de COVID-19 durante la pandemia de 2020, este registro de registro se publicó automáticamente exactamente como se envió. El equipo de PROSPERO no ha verificado la elegibilidad. Citación Yawen Yu, Eric Anson, Joshua Haworth, Shelly Lane, Peter Agada. Efectos de la hipoterapia o la equitación terapéutica sobre el equilibrio, el control postural y la movilidad funcional en la esclerosis múltiple: un metaanálisis. PROSPERO 2020 CRD42020218716 Disponible en: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020218716 Pregunta de revisión ¿Cómo impacta la hipoterapia o la equitación terapéutica en el control postural, el equilibrio y la movilidad funcional en las personas con esclerosis múltiple? Búsquedas Bases de datos: PubMed, CINAHL, PEDro, PsycINFO, SPORTDiscus, Web of Science; Idioma: inglés; Resumen: Disponible Tipos de estudio a incluir Los estudios de ensayos clínicos deben incluir un grupo que se somete a hipoterapia o paseos terapéuticos a caballo, y otro grupo que recibe atención estándar (por ejemplo, fisioterapia, terapia ocupacional, programa de ejercicios) o ningún tratamiento. Además, las medidas de resultado deben adquirirse al inicio y después de la intervención. Se excluirán los estudios que utilicen estudios de caso o diseño de una sola asignatura. Condición o dominio en estudio Enfermedad: esclerosis múltiple; Dominio: control postural, equilibrio, movilidad funcional Participantes / población https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=218716

1/5

13/4/2021

https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=218716

Inclusión: adultos (> 18 años) con esclerosis múltiple; Exclusión: trastornos neurológicos distintos de la esclerosis múltiple. Intervención (es), exposición (es) El grupo experimental debe estar expuesto a hipoterapia o cabalgatas terapéuticas; Queda excluida la equitación a caballo mecánico o simulador de cabalgatas. Comparador (es) / control The control group may be standard care (e.g., PT, OT, balance exercise) or no treatment. Context No specific restrictions on context. Main outcome(s) The studies to be included in the SRMA should include at least one of the following outcome measures or alike at both pre-test and post-test. Postural Control: Center of Pressure, Balance Error Scoring System (BESS), Sensory Organization Test (SOT), Clinical Test of Sensory Integration on Balance (CTSIB), etc. Static and dynamic balance: Berg Balance Scale (BBS), Tinetti Performance Oriented Mobility Assessment (POMA), Balance Evaluation Systems Test (BESTest), etc. Functional mobility: Timed Up-and-Go (TUG), 6-Minute Walking Test (6MWT), 10-Meter Walking Test (10MWT), Dynamic Gait Index (DGI), Functional Gait Assessment (FGA), gait analysis, etc. Measures of effect For continuous data, we will use the mean difference with 95% CI for outcomes measured in the same way between trials. We will use the standardized mean difference (SMD) with 95% CI for outcomes measured by different instruments. Additional outcome(s) N/A Measures of effect N/A Data extraction (selection and coding) Study Selection: 1/ Citation Screening: Two review authors will independently screen the title and abstract for eligibility. Any disagreement will be resolved through discussion. 2/ Full-text Screening: Two review authors will independently screen the full text for eligibility. Any disagreement will be resolved through discussion. Covidence will be used as the platform for study screening and selection. Data Extraction: The following information will be extracted from each study: 1/ citation (e.g., first author name, year of publication), 2/ participant demographics and baseline characteristics (e.g., age of participants, time from diagnosis, MS severity [EDSS] at baseline), 3/ study design (e.g., type https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=218716

2/5

13/4/2021

https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=218716

of intervention, treatment intensity, outcome measures), 4/ results. Two review authors will independently extract the data from all selected studies. Any disagreement will be resolved through discussion. Missing data will be handled via reaching out to the corresponding author of the original article for clarification. Covidence will be used for data extraction. Risk of bias (quality) assessment Two review authors will independently assess the risk of bias for each study using the criteria outlined in the Physiotherapy Evidence Database (PEDro) scale. Specific criteria to be assessed include random assignment, concealed allocation, similarity at baseline, blinding process regarding the participants, therapists, and assessors, percentage of participants assessed by outcome measures, analysis of treatment effect, the statistical report on between-group effects, report of marginal mean and variation at pre-test and post-test. A PEDro total score will be assigned to each study based on the aforementioned criterion. Any disagreement will be resolved through discussion. Strategy for data synthesis Data synthesis will focus on the composition of groups which may include different inclusion and exclusion criteria, different baseline levels), the dosage of intervention, the proportion of subject drop-outs, activities involved in hippotherapy and/or therapeutic horseback riding, etc. For studies using parallel study design (i.e. exp group vs. ctrl group), we will undertake meta-analyses if the outcome measures address postural control, balance, or functional mobility. Standardized mean differences from the outcome measures with continuous data will be used to estimate the treatment effect. Los metanálisis se realizarán utilizando el software Comprehensive Meta-Analysis (CMA) Ver.3. Planeamos utilizar la diferencia de medias estandarizada con un intervalo de confianza del 95% para combinar los datos de las medidas de resultado primarias de múltiples estudios con el modelo de efectos aleatorios. Se esperan diferentes instrumentos para las medidas de resultado primarias. Se utilizarán diagramas de bosque para evaluar visualmente el grado de heterogeneidad. La heterogeneidad entre ensayos también se evaluará mediante las pruebas I²; valores superiores al 50% se considerarían heterogeneidad. Se utilizarán gráficos en embudo y las pruebas de Egger para examinar el posible sesgo de publicación. Análisis de subgrupos o subconjuntos If the number of studies turns out to be sufficient to carry out subgroup analyses, we plan to conduct separate subgroup meta-analyses on three domains: postural stability, static and dynamic balance, and functional mobility. This will allow the inspection into whether hippotherapy or therapeutic horseback riding may have a differential effect on these domains where the intervention effect is expected to act upon. The inclusion and exclusion criteria are expected to be the same as the core meta-analysis mentioned in the previous sessions. Contact details for further information Yawen Yu [email protected] Organisational affiliation of the review Colorado State University Review team members and their organisational affiliations https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=218716

3/5

13/4/2021

https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=218716

Dr Yawen Yu. Colorado State University Dr Eric Anson. University of Rochester Medical Center Dr Joshua Haworth. Oakland University Dr Shelly Lane. Colorado State University Mr Peter Agada. Colorado State University Type and method of review Meta-analysis, Systematic review Anticipated or actual start date 18 November 2020 Anticipated completion date 30 June 2021 Funding sources/sponsors N/A Grant number(s) State the funder, grant or award number and the date of award N/A Conflicts of interest Language (there is not an English language summary) Country United States of America Stage of review Review Ongoing Subject index terms status Subject indexing assigned by CRD

https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=218716

4/5

13/4/2021

https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=218716

Subject index terms MeSH headings have not been applied to this record Date of registration in PROSPERO 17 December 2020 Date of first submission 16 November 2020 Stage of review at time of this submission The review has not started Stage

Started

Completed

Preliminary searches

No

No

Piloting of the study selection process

No

No

Formal screening of search results against eligibility criteria

No

No

Data extraction

No

No

Risk of bias (quality) assessment

No

No

Data analysis

No

No

The record owner confirms that the information they have supplied for this submission is accurate and complete and they understand that deliberate provision of inaccurate information or omission of data may be construed as scientific misconduct. The record owner confirms that they will update the status of the review when it is completed and will add publication details in due course. Versions 17 December 2020

PROSPERO Esta información ha sido proporcionada por el contacto designado para esta revisión. CRD ha aceptado esta información de buena fe y ha registrado la revisión en PROSPERO. El solicitante de registro confirma que la información proporcionada para este envío es precisa y completa. CRD no asume ninguna responsabilidad por el contenido de este registro de registro, los archivos asociados o los sitios web externos.

https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=218716

5/5